Campus Alert: Find the latest UMMS campus news and resources at umassmed.edu/coronavirus

Search Close Search

Print

2021 Press Releases

-Archives-

Research by Mark Johnson provides insights into origins of idiopathic normal pressure hydrocephalus

Research by Mark Johnson provides insights into origins of idiopathic normal pressure hydrocephalus

A UMass Medical School neurosurgery research team has unlocked a genetic component underlying a mysterious brain disorder known as idiopathic normal pressure hydrocephalus, a condition whose symptoms are often mistakenly attributed to other diseases or age.

Preventative shot for Lyme disease, developed at UMass Medical School, enters clinical trial

Preventative shot for Lyme disease, developed at UMass Medical School, enters clinical trial

Lyme PrEP, a seasonal shot to prevent Lyme disease developed by MassBiologics at UMass Medical School, has begun enrolling volunteers to evaluate the safety and pharmacology of the treatment.

UMass Medical School joins JDRF Center of Excellence in New England to advance type 1 diabetes research

UMass Medical School joins JDRF Center of Excellence in New England to advance type 1 diabetes research

Five UMass Medical School scientists from the UMass Diabetes Center of Excellence are part of the JDRF Center of Excellence in New England that launched Feb. 23. The goal of the is to create a cell replacement therapy that could treat and potentially cure type 1 diabetes.

UMass Medical School launches Vaccine Corps, backed by philanthropy, to support statewide vaccine rollout

UMass Medical School launches Vaccine Corps, backed by philanthropy, to support statewide vaccine rollout

Philanthropic donations totaling $435,000 have been raised to support the Vaccine Corps launched by UMass Medical School.

UMass Medical School students among volunteers at opening of Worcester’s first large-scale vaccine site

UMass Medical School students among volunteers at opening of Worcester’s first large-scale vaccine site

Medical students Kaan Apaydin, Kara Kennedy, Alex Richard and Erica Christenson take part in the opening of Worcester’s first large-scale COVID-19 vaccination site.

FDA approves Investigational New Drug Application for DNA/prime-protein boost vaccine to prevent HIV infections

FDA approves Investigational New Drug Application for DNA/prime-protein boost vaccine to prevent HIV infections

Worcester HIV Vaccine has received clearance from the FDA for its Investigational New Drug application for a novel polyvalent DNA/prime-protein boost vaccine to prevent HIV.

Child Psychiatry Access Project for Autism Spectrum Disorder at the ready during pandemic

Child Psychiatry Access Project for Autism Spectrum Disorder at the ready during pandemic

The Eunice Kennedy Shriver Center at UMass Medical School helped launch new psychiatric emergency service to help Massachusetts youth and families as confinement at home and loss of outside supports have exacerbated behavioral health crises.

UMass Medical School announces partnership in large-scale COVID-19 vaccination site in Worcester

UMass Medical School announces partnership in large-scale COVID-19 vaccination site in Worcester

UMass Medical School, in partnership with the Commonwealth of Massachusetts, the City of Worcester, Worcester State University and Saint Vincent Hospital, will play an integral role in a COVID-19 mass vaccination site that will open later this month on the campus of Worcester State.

First patient dosed in clinical trial of gene therapy for Tay-Sachs and Sandhoff diseases

First patient dosed in clinical trial of gene therapy for Tay-Sachs and Sandhoff diseases

Sio Gene Therapies announced that the first patient with infantile Tay-Sachs disease has been dosed in a Phase I/II trial evaluating AXO-AAV-GM2, an investigational gene therapy for the treatment of GM2 gangliosidosis, which causes Tay-Sachs and Sandhoff diseases. Miguel Sena-Esteves, PhD, is a principal scientist of the research program at UMMS.

UMMS researchers track COVID virus changes, community spread, as part of surveillance network

UMMS researchers track COVID virus changes, community spread, as part of surveillance network

UMass Medical School researchers are working with a statewide network in partnership with the Broad Institute of MIT and Harvard and the U.S. Centers for Disease Control and Prevention to determine the extent of SARS-CoV-2 mutations in the Worcester area and what role they might play in community spread.

Showing 1-10 of 21 items
of 3